Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
J Magn Reson Imaging ; 43(6): 1407-16, 2016 06.
Article in English | MEDLINE | ID: mdl-26587694

ABSTRACT

PURPOSE: To evaluate serial apparent diffusion coefficient (ADC) measurements of bone metastases in prostate cancer to determine whether antiandrogen resistance can be detected and time to progression estimated. MATERIALS AND METHODS: Diffusion-weighted imaging (DWI) was performed at 1.5T in nine patients with treatment-naïve metastatic prostate cancer (20 lesions) before antiandrogen treatment, after 1, 2, and 3 months of treatment, and thereafter every 4 months over 31 months or until antiandrogen resistance was detected. Tumor volumes were stable over time. Time courses of the ADCs when averaged over entire lesions and on functional diffusion maps (fDMs) were analyzed using marginal linear model (MLM) analysis. RESULTS: Starting at 1 month, MLM analysis revealed decreasing mean ADCs (P = 0.001) over time. Simultaneously, the percentage of voxels with significantly higher ADCs decreased (P = 0.004), whereas the percentage of voxels with significantly lower ADCs increased (P < 0.001) on fDMs. Both mean ADCs (P = 0.042) and percentages of voxels with significantly higher ADCs on fDMs (P = 0.039) decreased more rapidly over time in patients with a shorter progression-free interval (PFI). Likewise, higher (P = 0.001) and more rapidly increasing (P = 0.002) percentages of voxels with significantly lower ADCs on fDMs were associated with a shorter PFI. CONCLUSION: The results of our pilot study suggest that the evolution of ADCs over time may permit early identification of antiandrogen resistance in bone metastases. J. Magn. Reson. Imaging 2016;43:1407-1416.


Subject(s)
Androgen Antagonists/administration & dosage , Bone Neoplasms/drug therapy , Bone Neoplasms/secondary , Diffusion Magnetic Resonance Imaging/methods , Drug Monitoring/methods , Prostatic Neoplasms/diagnostic imaging , Prostatic Neoplasms/drug therapy , Aged , Aged, 80 and over , Antineoplastic Agents/administration & dosage , Bone Neoplasms/pathology , Drug Resistance, Neoplasm , Humans , Male , Pilot Projects , Prognosis , Prostatic Neoplasms/pathology , Reproducibility of Results , Sensitivity and Specificity , Treatment Outcome
2.
Eur J Radiol ; 101: 184-190, 2018 Apr.
Article in English | MEDLINE | ID: mdl-29571795

ABSTRACT

OBJECTIVE: To evaluate whole-lesion volumetric texture analysis of apparent diffusion coefficient (ADC) maps for assessing treatment response in prostate cancer bone metastases. MATERIALS AND METHODS: Texture analysis is performed in 12 treatment-naïve patients with 34 metastases before treatment and at one, two, and three months after the initiation of androgen deprivation therapy. Four first-order and 19 second-order statistical texture features are computed on the ADC maps in each lesion at every time point. Repeatability, inter-patient variability, and changes in the feature values under therapy are investigated. Spearman rank's correlation coefficients are calculated across time to demonstrate the relationship between the texture features and the serum prostate specific antigen (PSA) levels. RESULTS: With few exceptions, the texture features exhibited moderate to high precision. At the same time, Friedman's tests revealed that all first-order and second-order statistical texture features changed significantly in response to therapy. Thereby, the majority of texture features showed significant changes in their values at all post-treatment time points relative to baseline. Bivariate analysis detected significant correlations between the great majority of texture features and the serum PSA levels. Thereby, three first-order and six second-order statistical features showed strong correlations with the serum PSA levels across time. CONCLUSION: The findings in the present work indicate that whole-tumor volumetric texture analysis may be utilized for response assessment in prostate cancer bone metastases. The approach may be used as a complementary measure for treatment monitoring in conjunction with averaged ADC values.


Subject(s)
Bone Neoplasms/diagnostic imaging , Bone Neoplasms/secondary , Magnetic Resonance Imaging/methods , Prostatic Neoplasms/drug therapy , Prostatic Neoplasms/pathology , Aged , Aged, 80 and over , Humans , Male , Pilot Projects , Prospective Studies , Treatment Outcome , Whole Body Imaging/methods
3.
Sci Rep ; 7(1): 5809, 2017 07 19.
Article in English | MEDLINE | ID: mdl-28724944

ABSTRACT

Diffusion-weighted imaging quantified using the mono-exponential model has shown great promise for monitoring treatment response in prostate cancer bone metastases. The aim of this prospective study is to evaluate whether non-mono-exponential diffusion models better describe the water diffusion properties and may improve treatment response assessment. Diffusion-weighted imaging data of 12 treatment-naïve patients with 34 metastases acquired before and at one, two, and three months after initiation of antiandrogen treatment are analysed using the mono-exponential, the intravoxel incoherent motion, the stretched exponential, and the statistical model. Repeatability of the fitted parameters and changes under therapy are quantified. Model preference is assessed and correlation coefficients across times are calculated to delineate the relationship between the prostate-specific antigen levels and the diffusion parameters as well as between the diffusion parameters within each model. There is a clear preference for non-mono-exponential diffusion models at all time points. Particularly the stretched exponential is favoured in approximately 60% of the lesions. Its parameters increase significantly in response to treatment and are highly repeatable. Thus, the stretched exponential may be utilized as a potential optimal model for monitoring treatment response. Compared with the mono-exponential model, it may provide complementary information on tissue properties and improve response assessment.


Subject(s)
Bone Neoplasms/secondary , Bone Neoplasms/therapy , Diffusion Magnetic Resonance Imaging , Prostatic Neoplasms/pathology , Aged , Aged, 80 and over , Diffusion , Humans , Male , Models, Biological , Prostate-Specific Antigen/metabolism , Reproducibility of Results
4.
AJNR Am J Neuroradiol ; 26(8): 2117-21, 2005 Sep.
Article in English | MEDLINE | ID: mdl-16155168

ABSTRACT

In the differential diagnosis of midface masses, the nevus of Ota (also called oculodermal melanocytosis) is a rare entity. We present a case of a young white man, who lost his left eye function by progression of a melanocytotic lesion involving the ophthalmic (VI) and maxillary (VII) divisions of the trigeminal nerve. The time course, distribution along the trigeminal nerve, and characteristic MR signal intensities of the lesion, in correlation with the clinical, ophthalmological, and dermatological findings, point to the correct diagnosis.


Subject(s)
Magnetic Resonance Imaging , Neoplasms, Multiple Primary/diagnosis , Nerve Sheath Neoplasms/diagnosis , Nevus of Ota/diagnosis , Orbital Neoplasms/diagnosis , Peripheral Nervous System Neoplasms/diagnosis , Skin Neoplasms/diagnosis , Adolescent , Diagnosis, Differential , Exophthalmos/etiology , Humans , Male , Neoplasm Invasiveness , Neoplasms, Multiple Primary/pathology , Nerve Sheath Neoplasms/pathology , Nevus of Ota/complications , Nevus of Ota/pathology , Orbital Neoplasms/pathology , Peripheral Nervous System Neoplasms/pathology , Skin Neoplasms/complications , Skin Neoplasms/pathology , Trigeminal Nerve/pathology
SELECTION OF CITATIONS
SEARCH DETAIL